Immix Biopharma, Inc. (IMMX)
9.22
+0.22
(+2.44%)
USD |
NASDAQ |
Jun 01, 16:00
9.22
0.00 (0.00%)
After-Hours: 20:00
Immix Biopharma Total Liabilities (Quarterly) : 11.45M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 3.638M |
| Relay Therapeutics, Inc. | 57.43M |
| Annexon, Inc. | 58.36M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 95.82M |
| Shareholders Equity (Quarterly) | 84.36M |
| Debt to Equity Ratio | 0.0123 |
| Current Ratio | 8.755 |
| Net Debt Paydown Yield | 0.00% |